Wolfgang Miesbach on Differential Diagnosis of Thrombocytopenia
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn:
”Today, our review article on the differential diagnosis of thrombocytopenia was published in the German Medical Journal – a comprehensive overview for clinical practice.
Why is this topic important?
Thrombocytopenia (platelet count < 150,000/µL) is a common coagulation disorder with significant clinical implications.
Approximately 90% of cases can be attributed to immune-mediated diseases, drug-induced forms, pregnancy-associated thrombocytopenia, or infections.
Most common causes:
- Pregnancy-associated thrombocytopenia
- Idiopathic thrombocytopenic purpura (ITP)
- Drug-induced forms (e.g., HIT with unfractionated heparin up to 1%)
- Infections and systemic diseases
Recognizing critical emergencies:
Life-threatening situations such as thrombotic thrombocytopenic purpura (TTP), heparin-induced thrombocytopenia (HIT), and disseminated intravascular coagulation (DIC) require immediate action.
Structured approach:
The publication offers a practice-oriented diagnostic algorithm that:
– Rules out pseudothrombocytopenia
– Identifies red flags
– Distinguishes between elective and emergency investigations
– Highlights specific treatment options
Take-home message:
Systematic differential diagnosis is crucial for initiating targeted therapies and preventing complications.
The paper offers practical guidance for both general practitioners and specialists.
The complete CME-certified publication is now available in Deutsches Ärzteblatt and offers 3 CME credits.
Many thanks and congratulations to the co-authors!”
Read the full article here.
Article: Differential diagnosis of thrombocytopenia
Authors: Miesbach Wolfgang, Stratmann Jan, Alesci Rosa Sonja, Chromik Jörg, Bakchoul Tamam, Wendt Ralph
Stay updated on all scientific advances in the field of platelet disorders with Hemostasis Today.
-
Sep 10, 2026, 11:25Andreas Glenthøj: New Sickle Cell Trait Data in UpToDate
-
Sep 10, 2026, 10:53A New Era of Hemophilia Screening and Diagnosis in Women and Girls – ISTH
-
Sep 10, 2026, 10:03Investing in Youth, Transforming Hemophilia Care – WFH
-
Sep 10, 2026, 09:51Ronke Oke BEM: 20 Years of Newborn Sickle Cell Screening in England
-
Sep 10, 2026, 09:41Seunghwan Song: Hemlibra and the Science That Changed Hemophilia A Care
-
Sep 10, 2026, 09:20Mark Dawson: A Radical Rethink of Hemophilia Treatment
-
Sep 10, 2026, 07:26Carly Newton: Every Donation Helps Save Lives
-
Sep 10, 2026, 07:152023 ACR/EULAR APS Classification Criteria – APS Foundation of America
-
Sep 10, 2026, 07:03When Platelet Function Matters More Than Platelet Count – Glanzmann’s Research Foundation